Health Economics

The criteria used to determine access to drugs, devices, and medical procedures have changed. It is no longer enough to address only the traditional clinical parameters of efficacy and safety. Your product must also show real-world effectiveness and economic value.

To communicate your research and message, you need writers who are versed in both the clinical and economic aspects of health care.

We have prepared health economics and outcomes research (HEOR) content for more than 15 years, including the following document types:

  • AMCP and NAMCP dossiers, and other types of product value dossiers

  • Cost-effectiveness and budget impact analyses

  • Retrospective database and patient registry studies

  • HEOR advisory board and conference coverage.

  • Evaluations of health-related quality of life and patient-reported outcomes

  • Scientific content targeted to payer/purchaser audiences

  • Product- or disease-specific reviews that synthesize clinical and health economics research

  • White papers, blogs, and targeted communications that describe the health and financial impact of new treatments and technologies

Health Economics  · QALY ·  ICER · Cost-effectiveness · AMCP dossiers · Productivity · Incremental · Payers · Managed care · Dominant strategy · HEOR · Markov · Budget impact · Pharmacoeconomics · Real-world evidence  ·  Retrospective database · Transparency  ·   MAIC  ·  Value story  · 
PPOs  · PRO  · Propensity scoring  ·  EuroQoL